Overview of the MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to ...

Traversing the legal process with a birth injury lawyer in Houston can seem formidable, but it’s a crucial step in securing ...

Highlights Second quarter 2025 revenue of $213.1 million increased by 1% year-over-year. Excluding previously discussed ...

Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from ...

Gross margin of 71.2% increased over 160 basis points year-over-year, and optimism for new product lines, In Q1 2025, revenue declined by 3% year-over-year, but excluding headwinds of $16 million, ...

Appropriately-timed and suitably-performed scans are crucial for improving pregnancy outcomes and early intervention strategies.

Fetal alcohol syndrome (FAS) is 100% preventable as an environmental cause of intellectual disability and represents the most ...

The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...

If your pregnancy is high-risk, it means that you'll need special care – but you can still have a healthy pregnancy, labor, and delivery.

Nearly 40 years ago when Lis Dreizen's daughter Olivia was born with a congenital heart defect, doctors were grim about her chances to live. "I would cry simply looking at Olivia, and it was very ...

San Diego, CA, July 28, 2025 -- Dionysus Health, the molecular diagnostics company behind myLuma ™, and Mammha, a leading provider of accessible, full-spectrum perinatal mental health care, today ...